Report adverse events to FDA MedWatch at fda.gov/medwatch or 1-800-FDA-1088.
Wegovy (semaglutide) is an injectable medication that is used with a reduced-calorie diet and increased exercise to help manage chronic weight in adults who are: Obese (body mass index = 30 kg/m2) OR Overweight (body mass index = 27 kg/m2) with at least one weight-related condition (e.g., high blood pressure, diabetes, high cholesterol) Wegovy is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist
Should I commit to a specific diet or exercise program
Known as the body's master antioxidant, glutathione plays a vital role in detoxification, immune function, and skin brightening
Its essential to consult a healthcare provider before combining Tirzepatide with other weight loss medications
Since semaglutide has a direct effect on the GI tract, a majority of the side effects are gastrointestinal-related